<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CASP5</id>
	<title>CASP5 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CASP5"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CASP5&amp;action=history"/>
	<updated>2026-07-19T02:25:34Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CASP5&amp;diff=6046&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Caspase-5 precursor (EC 3.4.22.58) (CASP-5) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Contains: Caspase-5 subunit p20; Caspase-5 subunit p10] [ICH3]  ==Publi...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CASP5&amp;diff=6046&amp;oldid=prev"/>
		<updated>2021-05-12T15:08:27Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Caspase-5 precursor (EC 3.4.22.58) (CASP-5) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Contains: Caspase-5 subunit p20; Caspase-5 subunit p10] [ICH3]  ==Publi...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Caspase-5 precursor (EC 3.4.22.58) (CASP-5) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Contains: Caspase-5 subunit p20; Caspase-5 subunit p10] [ICH3]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Gene expression of inflammasome components in peripheral blood mononuclear cells (PBMC) of vascular patients increases with age.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26448778&lt;br /&gt;
|abstract=Chronic low-grade inflammation is considered a driver of many age-related disorders, including vascular diseases (inflammaging). Inhibition of autophagic capacity with ageing was postulated to generate a pro-inflammatory condition via activation of inflammasomes, a group of Interleukin-1 activating intracellular multi-protein complexes. We thus investigated gene expression of inflammasome components in PBMC of 77 vascular patients (age 22-82) in association with age. Linear regression of real-time qRT-PCR data revealed a significant positive association of gene expression of each of the inflammasome components with age (Pearson correlation coefficients: [[AIM2]]: r = 0.245; P = 0.032; [[NLRP3]]: r = 0.367; P = 0.001; ASC (PYCARD): r = 0.252; P = 0.027; [[CASP1]]: r = 0.296; P = 0.009; [[CASP5]]: r = 0.453; P = 0.00003; [[IL1B]]: r = 0.247; P = 0.030). No difference in gene expression of [[AIM2]], [[NLRP3]], ASC [[CASP1]], and [[CASP5]] was detected between PBMC of patients with advanced atherosclerosis and other vascular patients, whereas [[IL1B]] expression was increased in PBMC of the latter group (P = 0.0005). The findings reinforce the systemic pro-inflammatory phenotype reported in elderly by demonstrating an increased phase-1 activation of inflammasomes in PBMC of vascular patients.&lt;br /&gt;
&lt;br /&gt;
|keywords=* AIM2&lt;br /&gt;
* Aging&lt;br /&gt;
* Atherosclerosis&lt;br /&gt;
* Inflammation&lt;br /&gt;
* NLRP3&lt;br /&gt;
* Vascular disease&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596365&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Evidence for depletion of [[CASP5]] Ala90Thr heterozygous genotype in aged subjects.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/20434535&lt;br /&gt;
|abstract=Our previous studies, which included genotyping of multiple coding apoptotic gene polymorphisms, unexpectedly demonstrated a depletion of heterozygous [[CASP5]] Ala90Thr (rs507879, c.268 G&amp;gt;A) genotypes in elderly subjects. Present investigation was aimed to validate this trend. An analysis of 510 subjects aged 75-103years revealed 205 (40%) [[CASP5]] Ala90Thr heterozygotes as compared to 254 (50%) expected from the minor allele frequency 0.470 (p=0.000014). This deviation was not observed in 549 middle-aged (18-50years) controls (270 (49%) heterozygotes observed vs. 274 (50%) expected; minor allele frequency 0.475; p=0.743). Unfavorable significance of [[CASP5]] heterozygous genotype may be explained by the role of the caspase-5 in inflammation-related processes. Almost all prior gene-longevity association studies focused on discrimination between &amp;quot;good&amp;quot; and &amp;quot;bad&amp;quot; gene variants. Here we present a distinct situation, where the combination of alternative alleles (i.e., heterozygosity) appears to be unfavorable as compared to the homozygous carriership of either gene variant.&lt;br /&gt;
|mesh-terms=* Adolescent&lt;br /&gt;
* Adult&lt;br /&gt;
* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Amino Acid Substitution&lt;br /&gt;
* Apoptosis&lt;br /&gt;
* Caspases&lt;br /&gt;
* DNA Primers&lt;br /&gt;
* Gene Frequency&lt;br /&gt;
* Genotype&lt;br /&gt;
* Heterozygote&lt;br /&gt;
* Homozygote&lt;br /&gt;
* Humans&lt;br /&gt;
* Longevity&lt;br /&gt;
* Lung Neoplasms&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Polymerase Chain Reaction&lt;br /&gt;
* Polymorphism, Genetic&lt;br /&gt;
* Smoking&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.exger.2010.04.007&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>